As various diseases have been discovered and characterized, the development of diagnostic and therapeutic methods has become increasingly important. A critical first step is to understand biological phenomena and disease at the molecular level and to design (1) efficient analytical tools for monitoring biomolecular interactions and (2) chemical tools for regulating biological functions. To achieve these goals, we create novel functional biomolecules through chemical modification of natural biomolecules and develop “functional biomolecular systems” that can be applied in biology, chemical biology, bioorganic chemistry, and medicinal chemistry.
Templated chemistry has been achieved due to the enhanced local concentration of reactants arising from attractive interactions between biomolecules. Through this unique reaction, several biomolecular operations, such as synthesis, cleavage, and transformation, can be conducted. Based on these operations, we develop biomolecular circuits that can be employed for important diagnostic and therapeutic applications, including biomolecule sensing, site-specific functionalization of biomolecules, bioactive molecule (drug) release, and the regulation of biological processes.
References
[1] Chem. Commun. 2022, 58, 13743-13746.
[2] Bioconjugate Chem. 2023, 34, 1606-1612.
[3] Org. Biomol. Chem. 2024, 22, 8182–8188.
DNA-encoded libraries (DELs) have become an important platform in modern drug discovery by enabling the efficient screening of vast small-molecule chemical space. DEL construction relies on on-DNA synthesis, where diverse compounds are assembled under DNA-compatible conditions while preserving the encoding tags. In this context, we pursue research to develop and expand robust on-DNA reactions and scaffold-forming strategies, ultimately advancing DEL-based hit discovery and lead generation.
References
[1] Org. Lett. 2025, 27, 13134–13139.